Clinical trial
A 6-month, open-label extension to a 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin� LA in the treatment of adult patients with childhood-onset ADHD
To evaluate the long-term safety of Ritalin LA administered once daily for six months during open-label treatment in adults with ADHD.
| Category | Value |
|---|---|
| Study start date | 2011-05-05 |